ArticleClinical pharmacology in drug development2019

A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control Participants.

Ridhi Parasrampuria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.